Condition: Recurrent Gynecologic Cancer · Recurrent Uterine Cancer · Recurrent Cervical Cancer · Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy
REGYNERA(dia)TION is an international, multicenter, ambispective observational patient registry of adults with recurrent gynecologic malignancies after prior radiotherapy who are treated or planned for reirradiation and/or total ablative strategies as part of routine clinical care. The registry does not assign treatment. Radiotherapy technique, dose, systemic therapy, surgery, metastasis-directed therapy, imaging, and follow-up are selected by the treating multidisciplinary team according to local standards and patient-specific factors. The registry will collect harmonized retrospective and prospective data on disease characteristics, prior radiotherapy, recurrence pattern, reirradiation or ablative treatment exposure, response, progression, survival, severe treatment-related morbidity, fistula events, and patient-reported outcomes where available.
This description comes directly from the study's public registry record.
Mateusz Bilski, Md, PhD · 84 535 99 10 · mateusz.bilski@affidea.com
Paulina Kleban, MGR · 84 535 99 10 · paulina.kleban@affidea.com
Always discuss trial participation with your own doctor first.
| Affidea NU-MED Center of Oncological Diagnostics and Therapy | Zamość, Lublin Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07667192